Anaergia Inc. (“Anaergia”, the “Company”, “us”, or “our”) (TSX: ANRG), today announced its financial results for the three- and nine-month periods ended September 30, 2024 (“Q3 2024”), and the related management’s discussion and analysis (“MD&A”) for the period. Certain highlights from these financial results and from the MD&A follow. All financial results are reported in Canadian dollars unless otherwise stated.
LUXEMBOURG, July 10, 2024 /CNW/ – Marny Investissement SA (“Marny”) reports that it has completed, through its wholly owned subsidiary Marny Holdco Inc. (“Marny Holdco”), the third and final tranche of its previously announced arm’s-length non-brokered private placement of 102,000,000 units (each, a “Unit”) of Anaergia Inc.
Anaergia, a Canada-based anaerobic digestion solutions provider, has announced a CAD 40.8 million ($30.6 million) equity investment by Marny Investissement SA, a Luxembourg-based holding company, through
The company was able to secure Marny’s final round of investment after reporting its financial results. Founder Andrew Benedek was also replaced in his role as chairman of the board.